TITLE

Top of the Charts

PUB. DATE
August 2009
SOURCE
Pharmaceutical Representative;Aug2009, Vol. 39 Issue 8, p12
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Several charts are presented illustrating the top pharmaceutical companies as well as their 2008 global sales, the top therapeutic classes, and the top ten global therapeutic products.
ACCESSION #
43637429

 

Related Articles

  • By the Numbers.  // Pharmaceutical Representative;Jun2010, Vol. 40 Issue 6, p12 

    Several charts are presented showing the marketing performance of several pharmaceutical companies in the U.S. including Pfizer Inc., Sanofi-Aventis, and Novartis AG, along with the leading sales of therapeutics and pharmaceutical products.

  • Market Data.  // U.S. Pharma & Healthcare Report;Q2 2008, p78 

    Several charts are presented that list the leading 10 therapeutic classes by U.S. sales, the top 10 pharmaceutical products by U.S. sales, and the leading pharmaceutical corporations by U.S. sales in 2006.

  • Drug & Device Pipeline News.  // CenterWatch Weekly;6/23/2014, Vol. 18 Issue 25, p7 

    A table is presented which lists several pharmaceutical companies offering drugs and devices as of June 23, 2014 including Cara Therapeutics, PsiOxus Therapeutics, and Protalix BioTherapeutics.

  • The Week's Biggest Gainers and Losers.  // BioWorld Insight;9/12/2011, Vol. 19 Issue 37, p20 

    Several charts are presented which list the top 10 pharmaceuticals that gain big and loss as of the week of September 12, 2011, including Cleveland Biolabs Inc., Optimer Pharmaceuticals Inc., and Allos Therapeutics Inc.

  • Market Pulse.  // Pharmaceutical Executive;Aug2000, Vol. 20 Issue 8, p112 

    Presents graphical representations of the top five pharmaceutical companies and prescription brands in the United States in 1999.

  • Market Pulse.  // Pharmaceutical Executive;Oct99, Vol. 19 Issue 10, p106 

    Presents two charts that show the top five prescription drug brands and companies between January to June, 1998 and the same period for 1999.

  • Phase III Clinical Trials Update: May 2011.  // BioWorld Insight;6/13/2011, Vol. 19 Issue 24, p16 

    A table is presented on the status of Phase III clinical trials of therapeutic products from several pharmaceutical companies in May 2011 including the ProstAtak cancer vaccine from Amgen Inc., the Revlimid, a lenalidomide maintenance therapy from Celgene Corp., and the AMR101 omega-3 fatty acid...

  • Digestive Disease Week.  // BioWorld Insight;6/13/2011, Vol. 19 Issue 24, p20 

    A table is presented which lists the status and description of therapeutic products of pharmaceutical companies discussed at a conference on digestive disease held in Chicago, Illinois on 7-10, 2011 including the Vidofludimus, an oral inhibitor of interleukin-17 from 4SC AG, the ALKS 37...

  • Non-U.S. Clinical Trials & Regulatory Actions: May 2011.  // BioWorld Insight;6/13/2011, Vol. 19 Issue 24, p21 

    A table is presented on the status of the clinical trials and regulatory actions in non-U.S. countries on various therapeutic products from pharmaceutical companies in May 2011 including the Fampyra tablets from Acorda Therapeutics Inc., the Multikine immunotherapy from Cel-Sci Corp., and the...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics